Form 4 for TNON Tenon Medical, Inc.
Accepted 2025-12-19 00:00:00 ET · period of report 2024-11-05 · accession 0001213900-25-123961 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-19 | 2025-09-03 | TNON | Williamson Kevin | CFO, Dir | M - OptEx | $0.00 | +2,083 | 2,083 | New | $0 |
| D | 2025-12-19 | 2024-11-05 | TNON | Williamson Kevin | CFO, Dir | A - Grant | $0.00 | +6,250 | 6,250 | New | $0 |
| D | 2025-12-19 | 2025-09-03 | TNON | Williamson Kevin | CFO, Dir | M - OptEx | $0.00 | -2,083 | 4,167 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-03 | M | A | 2,083 | $0.00 | 2,083 | D | — | — | (F1) Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025. |
| 2 | Derivative | Restricted Stock Units | 2024-11-05 | A | A | 6,250 | $0.00 | 6,250 | D | — · — to — | 6,250 Common Stock | (F2) Represents a grant of 6,250 RSUs of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 2,083 RSUs on September 3, 2025; 1,041 RSUs on each of March 3, 2026, September 3, 2026, and March 3, 2027; and 1,044 on September 3, 2027. (F3) Each RSU represents a contingent right to receive one share of common stock of the Issuer. (F4) N/A |
| 3 | Derivative | Restricted Stock Units | 2025-09-03 | M | D | 2,083 | $0.00 | 4,167 | D | — · — to — | 2,083 Common Stock | (F1) Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025. (F3) Each RSU represents a contingent right to receive one share of common stock of the Issuer. (F4) N/A |